Brief: Rvl Pharmaceuticals PLC Reports Third Quarter 2022 Financial Results Provides Commercial Update
10/11/2022 21:32
Nov 10 (Reuters) -
* RVL PHARMACEUTICALS PLC REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS; PROVIDES COMMERCIAL UPDATE
* RVL PHARMACEUTICALS PLC QTRLY TOTAL REVENUE AND NET
PRODUCT
SALES, RELATING ENTIRELY TO NET PRODUCT SALES OF UPNEEQ, UP $7.8
MILLION TO $10.0 MILLION
* RVL PHARMACEUTICALS PLC - REAFFIRMS ITS GUIDANCE FOR NET
SALES
OF UPNEEQ FOR Q4 OF 2022
* RVL PHARMACEUTICALS PLC QTRLY LOSS PER SHARE $0.16
Source text for Eikon: ID:nGNX3PPbFV
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius